What question did this study set out to answer?

The aim is to assess the frequency, types, severity, and management of adverse drug reactions (ADRs) in chemotherapy patients.

Occurrence of adverse drug reactions in chemotherapy patients: A cross-sectional study

View Full Paper

Ask AI

Bookmark

Authors

Cross-sectional study assesses adverse drug reactions in chemotherapy patients, highlighting safety concerns.

The aim is to assess the frequency, types, severity, and management of adverse drug reactions (ADRs) in chemotherapy patients.
Cross-sectional study conducted over 12 months in a tertiary-care hospital
Included 327 chemotherapy patients
Utilized suspected ADR reporting forms and statistical analyses for causality and severity assessment
230 out of 327 patients developed ADRs (70% incidence)
372 ADRs reported, averaging 1.6 events per patient
Common ADRs included thrombocytopenia (11.2%) and neutropenia (9.9%)
Majority of ADRs categorized as 'possible' (36.1%) or 'probable' (61.7%)
Severity was primarily 'mild' (49.13%) or 'moderate' (46.08%)

Shyma et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark